-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
1-2-1 Meetings/Networking Break
-
Peptide CMC & Process Development
-
Peptide CMC & Process Development
Integrating peptide ligands into AAV capsids to enhance targeted delivery and cellular uptake, incre
...
-
Peptide CMC & Process Development
Stem cells used in novel cell therapies for respiratory, orthopedic, and wound healing indications n
...
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
How can we effectively integrate the design of oligonucleotides, small molecules, and conjugates int
...
-
Oligonucleotide CMC & Process Development
GRN‑1 leverages a lipid nanoparticle delivery system to deliver mRNA therapeutics targeting metaboli
...
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
Afternoon Refreshments
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
1-2-1 Meetings/Networking Break
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
Evening Drinks Reception
-
Oligonucleotide CMC & Process Development
Examine regulatory expectations and case studies on toxicity pathways specific to oligonucleotides a
...
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
The therapeutic potential of nucleic acids is expanding rapidly, but their rational design remains a
...
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
Strategic application of advanced analytical techniques can help improve selection of candidates and
...
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
1-2-1 Meetings/Networking Break
-
-
Oligonucleotides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
-
Drug Delivery
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
Networking Lunch
-
Oligonucleotide CMC & Process Development
Oligo chemical synthesis Downstream processing/purification Analytic development and specifications
...
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
Morning Refreshments
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
1-2-1 Meetings/Networking Break
-
-
Oligonucleotides CMC
-
Peptides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
1-2-1 Meetings/Networking Break
-
-
Oligonucleotides CMC
-
Innovation in Therapeutic Modalities
-
Translational & Clinical Strategy
Registration
-
Translational & Clinical Strategy
-
Translational & Clinical Strategy
Explore the latest advancements in oligo-based therapeutics including ASOs, siRNA, gRNA, miRNA, apta
...
-
Innovation in Therapeutic Modalities
-
Innovation in Therapeutic Modalities
Overcoming Challenges in eccDNA Detection and Direct Isolation Decoding the Biological Role of Circu
...
-
Oligonucleotide CMC & Process Development
Manufacturing of long RNA oligos: Synthesis and analytical strategies and challenges Scaling Up Oli
...
)
Strategic application of advanced analytical techniques can help improve selection of candidates and ...)
)
)
)
)
)
)
)
)
)
